Stockholders' Equity (Tables)

The fair values of the options granted during the Current Quarter were estimated at the date of grant using the Black-Scholes option pricing model with the following assumptions:

Expected Volatility	20.91	%
Expected Dividend Yield	0	%
Expected Life (Term)	2.50 years
Risk-Free Interest Rate	2.33	%

A summary of the Company’s stock options activity for the Current Quarter is as follows:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)		Aggregate Intrinsic Value
Outstanding at January 1, 2018		3,468,833	$	5.38		4.14	$	-
Granted		50,000		5.50
Canceled		-		-
Exercised		-		-
Expired/Forfeited		(20,499)		5.80
Outstanding at March 31, 2018, and expected to vest		3,498,334	$	5.38		3.91	$	-
Exercisable at March 31, 2018		1,726,422	$	5.64		3.19	$	-

The following table summarizes the Company’s stock option activity for non-vested options for the Current Quarter:

	Number of Options		Weighted Average Grant Date Fair Value
Balance at January 1, 2018		2,613,497	$	1.23
Granted		50,000		5.50
Vested		(874,419)		5.41
Forfeited or Canceled		(17,166)		5.80
Balance at March 31, 2018		1,771,912	$	5.12

A summary of the Company’s restricted stock activity for the Current Quarter is as follows:

	Number of Restricted Shares		Weighted Average Grant Date Fair Value
Outstanding at January 1, 2018		2,143,088	$	5.35
Granted		90,209		3.35
Canceled		-		-
Vested		(201,209)		4.21
Expired/Forfeited		-		-
Outstanding at March 31, 2018		2,032,088	$	5.37

A summary of the Company’s warrants activity for the Current Quarter is as follows:

	Number of Warrants		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)		Aggregate Intrinsic Value
Outstanding and exercisable at January 1, 2018		1,891,743	$	6.81		1.92	$	-
Granted		-		-
Canceled		-		-
Exercised		-		-
Expired/Forfeited		-		-
Outstanding and exercisable at March 31, 2018		1,891,743	$	6.81		1.67	$	-